Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep-wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light-dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep-wake schedules.
Molecular Weight:
245.32
Purity:
>99%
CAS Number:
[609799-22-6]
Formula:
C15H19NO2
Target:
Melatonin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
